XML 36 R11.htm IDEA: XBRL DOCUMENT v3.23.1
Investments
12 Months Ended
Dec. 31, 2022
Schedule of Investments [Abstract]  
Investments  
4.
  INVESTMENTS
Short-term Investments
As of December 31, 2021 and 2022, the Group’s short-term investments comprised of only debt securities. Short-term
held-to-maturity
securities were mainly deposits in commercial banks with maturities less than one year and wealth management products issued by commercial banks and other financial institutions for which the Group has the positive intent and ability to hold those securities to maturity. The short-term
available-for-sale
securities include wealth management products issued by commercial banks and other financial institutions which are not classified as trading securities or as
held-to-maturity
securities.
During the years ended December 31, 2020, 2021 and 2022, the Group recorded interest income from its short-term investments of
RMB4.7 billion, RMB4.5 billion and RMB4.5 billion (US$647 million) in the consolidated statements of comprehensive income, respectively.
 
Short-term investments classification as of December 31, 2021 and 2022 were shown as below:
 
    
As of December 31, 2021
 
    
Cost or
Amortized
cost less
allowance
for credit
losses
    
Gross
unrecognized
holding gains
    
Gross
unrecognized
holding
losses
    
Gross
unrealized
gains
    
Gross
unrealized
losses
    
Fair

value
 
  
RMB
    
RMB
    
RMB
    
RMB
    
RMB
    
RMB
 
    
(In millions)
 
Held-to-maturity
debt investments
     140,686        898        —          —          —          141,584  
Available-for-sale
debt investments
     2,547        —          —          10        —          2,557  
 
   
As of December 31, 2022
 
   
Cost or
Amortized
cost less
allowance
for credit
losses
   
Gross
unrecognized
holding gains
   
Gross
unrecognized
holding
losses
   
Gross
unrealized
gains
   
Gross
unrealized
losses
   
Fair value
 
 
RMB
   
RMB
   
RMB
   
RMB
   
RMB
   
RMB
   
US$
 
   
(In millions)
 
Held-to-maturity
debt investments
    119,984       631       (151     —         —         120,464       17,466  
Available-for-sale
debt investments
    847       —         —         8       —         855       124  
Long-term Investments
The following table sets forth a breakdown of the categories of long-term investments held by the Group as of the dates indicated:
 
    
As of December 31,
 
    
2021
    
2022
    
2022
 
    
RMB
    
RMB
    
US$
 
    
(In millions)
 
Equity investments at fair value with readily determinable fair value
     16,375        12,100        1,754  
Equity investments without readily determinable fair value using
the
NAV practical expedient
     957        945        137  
Equity investments without readily determinable fair value using
the
measurement alternative
     10,788        9,249        1,341  
Available-for-sale
debt investments
     2,262        2,447        355  
Equity method investments
     24,808        25,940        3,761  
Investments accounted for at fair value
     4,228        4,616        669  
    
 
 
    
 
 
    
 
 
 
Total long-term investments
     59,418        55,297        8,017  
    
 
 
    
 
 
    
 
 
 
Equity investments at fair value with readily determinable fair value
Equity investments at fair value with readily determinable fair value represent investments in the equity securities of publicly listed companies, for which the Group does not have significant influence.
 
Equity investments without readily determinable fair value
The Group accounted for private equity funds of which the Group does not have the ability to exercise significant influence using the NAV practical expedient in accordance with ASC 820. For equity investments without readily determinable fair value and do not qualify for the NAV practical expedient, the Group elected to use the measurement alternative to measure such investments at cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments of the same issuer, if any in accordance with ASC 321. Impairment charges recognized on equity investments without readily determinable fair value were
RMB
2,310 million, RMB4,259 million and RMB2,456 million (US$356 million) for the years ended December 31, 2020, 2021 and 2022, respectively.
The total carrying value of equity investments without readily determinable fair value that do not qualify for the NAV practical expedient held as of December 31, 2021 and 2022 were as follows:
 
    
As of

December 31,
2021
   
As of

December 31,
2022
   
As of

December 31,
2022
 
    
RMB
   
RMB
   
US$
 
    
(In millions)
 
Initial cost basis
     13,016       13,741       1,992  
Cumulative unrealized gains
     3,910       4,026       584  
Cumulative unrealized losses (including impairment)
     (6,138     (8,518     (1,235
    
 
 
   
 
 
   
 
 
 
Total carrying value
     10,788       9,249       1,341  
    
 
 
   
 
 
   
 
 
 
Total unrealized and realized gains and losses of equity securities without readily determinable fair values that do not qualify for
the
NAV practical expedient for the years ended December 31, 2020, 2021 and 2022 were as follows:
 
    
For the years ended

December 31,
 
    
2020
   
2021
   
2022
   
2022
 
    
RMB
   
RMB
   
RMB
   
US$
 
    
(In millions)
 
Gross unrealized gains
     4,396       1,062       218       32  
Gross unrealized losses (including impairment)
(i)
     (2,679     (4,424     (2,418     (351
    
 
 
   
 
 
   
 
 
   
 
 
 
Net unrealized gains (losses) on equity securities held
     1,717       (3,362     (2,200     (319
Net realized gains on equity securities sold
     266       —         90       13  
    
 
 
   
 
 
   
 
 
   
 
 
 
Total net gains (losses) recognized
     1,983       (3,362     (2,110     (306
    
 
 
   
 
 
   
 
 
   
 
 
 
 
(i)
Gross unrealized losses (downward adjustments excluding impairment) were RMB378 million, RMB165 million and nil for the years ended December 31, 2020, 2021 and 2022, respectively.
Equity method investments
The carrying amount of the Group’s equity method investments were
RMB24.8 billion and RMB25.9 billion (US$3.8 billion) as of December 31, 2021 and 2022, respectively. For the years ended December 31, 2020, 2021 and 2022, the impairment recognized for equity method investments were RMB297 million, RMB57 million and RMB569 million (US$82 million), respectively.
 
Equity Investment in Trip.com International, Ltd. (“Trip”) (formally known as Ctrip)
As of December 31, 2018, the Group held approximately
19%
of Trip’s outstanding shares. The Group was considered to have significant influence over Trip and accounts for such investment as an equity method investment in accordance with ASC 323. 
During 2019, the market value of Trip had significantly declined and remained below the carrying value of the investment for a prolonged period of time. Therefore, the Group concluded that the decline in market value of the investment in Trip was other-than-temporary as of September 30, 2019 and an impairment charge of
RMB8.9 
billion was recorded in the third quarter of 2019. The Group made a corresponding
RMB8.9 
billion downward adjustment to the equity method goodwill arising from its acquisition of the Trip investment.
In October 2019, the Group disposed an aggregate of
36 million American Depositary Shares of Trip for cash consideration of US$988 million and recognized a disposal loss of RMB43 million in the year ended December 31, 2019.
After the partial disposal of the investment in Trip, the Group held approximately
 
12
%
equity interest in Trip, and the Group can actively participate in the operating and financing policies of Trip through its
 
two
 
seats on Trip’s board of directors with a total of
 
nine
 
members. Accordingly, the Group continues to have significant influence over Trip and accounts for its remaining investment as an equity method investment in accordance with ASC 323. As of December 31, 2022, the Group’s investments in Trip had a fair value of
 
RMB
16.4
 billion (US$
2.4
 
billion), based on the closing share price.
The following tables set forth the summarized financial information of Trip:
 
    
As of September 30,
(i)
 
    
2021
    
2022
    
2022
 
    
RMB
    
RMB
    
US$
 
    
(In millions)
 
Current assets
     76,596        67,045        9,422  
Non-current
assets
     124,268        127,253        17,883  
Current liabilities
     73,517        61,708        8,672  
Non-current
liabilities
     16,418        21,647        3,042  
Noncontrolling interests
     924        713        100  
 
    
For the twelve months ended

September 30,
(i)
 
    
2020
   
2021
   
2022
   
2022
 
    
RMB
   
RMB
   
RMB
   
US$
 
    
(In millions)
 
Total revenues
     21,704       20,313       19,706       2,769  
Gross profit
     16,838       15,916       15,261       2,145  
Loss
 
from operations
     (827     (723     (376     (53
Net (loss) income
     (2,236     1,198       (1,596     (224
Net (loss) income attributable to
Trip
     (2,243     1,288       (1,488     (209
 
(i)
The Group adopted a
one-quarter
lag in reporting its share of equity income (loss) in Trip.
Equity Investment in Jidu Auto Inc. (“Jidu”)
In January 2021, the Group entered into an agreement with Zhejiang Geely Holding Group (“Geely”) to established Jidu to produce intelligent electric vehicles. In 2022, the Group purchased the ordinary shares with
amount of US$371 million including common stock of US$171 million and in-substance common stock of US$200 million, and preferred shares with amount of US$193 
million. After which, the Group holds an equity interest of
52.30% as of December 31, 2022.
However, considering the substantive participating rights held by Geely, the Group accounts for its investment of the ordinary shares as an equity method investment in accordance with ASC 323. Furthermore, the Group accounts for its investment of the preferred shares as an equity investment without a readily determinable fair value in accordance with ASC 321.
Disposal of financial services business
After finishing a series of legal restructuring and recapitalization of the financial services business (“Du Xiaoman”), the Group retained
 
41
%
of Du Xiaoman’s shares on a fully diluted basis, and accounted for it as an equity method investment in accordance with ASC 323, as the Group retained significant influence over Du Xiaoman. The carrying amount of the Du Xiaoman investment in excess of the Group’s proportionate interest in Du Xiaoman was recognized as equity method goodwill of
 RMB
3.5
 b
illion, intangible assets of RMB
851
 
m
illion and related deferred tax liabilities of RMB
213
 
m
illion.
As of December 31, 2021 and 2022, in addition to the aforementioned equity method investments, the Group held other equity method investments through its subsidiaries or VIEs and over which had significant influence.
For the year ended December 31, 2022, equity method investments excluding Trip held by the Group in aggregate have met the significance criteria as defined under
Rule 4-08(g) of
Regulation S-X.
Financial information for the Group’s equity method investments other than Trip are summarized as a group as follow:
 
    
As of September 30,
(i)
 
    
2021
    
2022
    
2022
 
    
RMB
    
RMB
    
US$
 
    
(In millions)
 
Current assets
     125,266        163,889        23,031  
Non-current
assets
     18,512        19,781        2,780  
Current liabilities
     90,744        117,811        16,556  
Non-current
liabilities
     9,218        15,750        2,213  
Noncontrolling interests
     1,662        1,721        242  
 
    
For the twelve months ended
September 30,
(i)
 
    
2020
   
2021
    
2022
    
2022
 
    
RMB
   
RMB
    
RMB
    
US$
 
    
(In millions)
 
Total revenues
     13,981       21,380        22,417        3,150  
Gross profit
     5,083       7,624        8,664        1,218  
(Loss) income from operations
     (1,282     1,238        993        140  
Net (loss) income
     (832     2,065        304        43  
Net (loss) income attributable to the investees
     (891     2,040        249        35  
 
(i)
The Group adopted a
one-quarter
lag in reporting its share of (loss) income in majority of its equity investees.
 
Investments accounted for at fair value
Long-term equity investments in unlisted companies held by consolidated investment companies are accounted for at fair value in accordance with ASC
946-320.
These investments are carried at fair value with realized or unrealized gains and losses recorded in “Others, net” in the consolidated statements of comprehensive income.
The methodology used in the determination of fair values for
held-to-maturity
debt investments,
available-for-sale
debt investments, equity investments with readily determinable fair values and other investment securities accounted for at fair value are disclosed in Note 26.
Long-term investments classification, excluding equity method investments and equity investments without readily determinable fair value, as of December 31, 2021 and 2022 are shown as below:
 
    
As of December 31, 2021
 
    
Cost or
Amortized cost
    
Gross
unrealized
gains
    
Gross
unrealized
losses
   
Fair
value
 
    
RMB
    
RMB
    
RMB
   
RMB
 
    
(In millions)
 
Equity investments at fair value with readily determinable fair value
     15,046        6,046        (4,717     16,375  
Available-for-sale
debt investments
     2,820        216        (774     2,262  
Investments accounted for at fair value
     1,974        2,653        (399     4,228  
 
    
As of December 31, 2022
 
    
Cost or
Amortized cost
    
Gross
unrealized
gains
    
Gross
unrealized
losses
   
Fair value
 
    
RMB
    
RMB
    
RMB
   
RMB
    
US$
 
    
(In millions)
 
Equity investments at fair value with readily
determinable fair value
     15,835        2,731        (6,466     12,100        1,754  
Available-for-sale
debt investments
     3,735        283        (1,571     2,447        355  
Investments accounted for at fair value
     2,331        2,855        (570     4,616        669  
Available-for-sale
debt investments
Available-for-sale
debt investments are convertible debt instruments issued by private companies and an investment in preferred shares that are redeemable at the Group’s option, which are measured at fair value. Investments in preferred shares that are redeemable at the Group’s option have no contractual maturity date.
The following table summarizes the estimated fair value of
available-for-sale
debt investments with stated contractual dates, classified by the contractual maturity date of the investments:
 
    
As of December 31,
 
    
2021
    
2022
    
2022
 
    
RMB
    
RMB
    
US$
 
    
(In millions)
 
Due in 1 year
     —          —          —    
Due in 1 year through 5 years
     1,685        1,581        229  
Not due at a single maturity date
     577        866        126  
    
 
 
    
 
 
    
 
 
 
Total
     2,262        2,447        355